4/16
10:59 am
auph
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference [Yahoo! Finance]
Low
Report
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference [Yahoo! Finance]
4/16
10:48 am
auph
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Low
Report
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
4/16
10:07 am
auph
Pelthos Therapeutics Establishes Board of Directors [Yahoo! Finance]
Low
Report
Pelthos Therapeutics Establishes Board of Directors [Yahoo! Finance]
4/15
06:00 am
auph
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
Medium
Report
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
4/9
06:00 am
auph
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
Low
Report
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
4/7
11:07 am
auph
When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven? [Yahoo! Finance]
Low
Report
When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven? [Yahoo! Finance]
3/8
02:11 pm
auph
We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn [Yahoo! Finance]
Low
Report
We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn [Yahoo! Finance]
3/1
02:44 pm
auph
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
2/29
08:40 am
auph
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program [Yahoo! Finance]
Low
Report
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program [Yahoo! Finance]
2/29
08:30 am
auph
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program
Low
Report
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program
2/27
08:30 am
auph
Aurinia to Participate in Upcoming Investor Healthcare Conferences
Low
Report
Aurinia to Participate in Upcoming Investor Healthcare Conferences
2/23
12:15 pm
auph
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Cantor Fitzgerald from $12.00 to $10.00. They now have an "overweight" rating on the stock.
Low
Report
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Cantor Fitzgerald from $12.00 to $10.00. They now have an "overweight" rating on the stock.
2/22
08:06 am
auph
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at HC Wainwright from $15.00 to $13.00. They now have a "buy" rating on the stock.
Medium
Report
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at HC Wainwright from $15.00 to $13.00. They now have a "buy" rating on the stock.
2/17
07:49 am
auph
Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations [Yahoo! Finance]
Medium
Report
Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations [Yahoo! Finance]
2/16
03:00 pm
auph
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH
2/16
02:05 pm
auph
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Jefferies Financial Group Inc. from $9.50 to $9.00. They now have a "hold" rating on the stock.
Low
Report
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Jefferies Financial Group Inc. from $9.50 to $9.00. They now have a "hold" rating on the stock.
2/16
11:39 am
auph
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $8.00. They now have an "outperform" rating on the stock.
Low
Report
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $8.00. They now have an "outperform" rating on the stock.
2/16
09:33 am
auph
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/15
03:17 pm
auph
Aurinia Pharmaceuticals 2023 Earnings Review: Calling 'Time' In Last Chance Saloon [Seeking Alpha]
Low
Report
Aurinia Pharmaceuticals 2023 Earnings Review: Calling 'Time' In Last Chance Saloon [Seeking Alpha]
2/15
08:52 am
auph
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
2/15
06:59 am
auph
Aurinia Pharmaceuticals Inc (AUPH) Announces Year-End Financial Results and Strategic Initiatives [Yahoo! Finance]
Medium
Report
Aurinia Pharmaceuticals Inc (AUPH) Announces Year-End Financial Results and Strategic Initiatives [Yahoo! Finance]
2/15
06:14 am
auph
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value [Yahoo! Finance]
High
Report
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value [Yahoo! Finance]
2/15
06:00 am
auph
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
High
Report
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
2/8
11:59 am
auph
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release [Yahoo! Finance]
Low
Report
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release [Yahoo! Finance]
2/5
08:30 am
auph
Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024
Low
Report
Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024